Medicines and raw materials for the pharmaceutical industry.
We are a Brazilian company, founded in 1984, which develops, manufactures and commercializes medicines and active pharmaceutical ingredients (APIs).
In medicines, we develop and manufacture high quality products in the HIV, hepatitis and osteoporosis segments, serving patients in Brazil through partnerships with the Ministry of Health and official laboratories.
Part of our strategy for expanding our pharmaceutical unit is to expand our presence in the international market through partnerships to export our medicines.
We are also looking for strategic alliances with international partners of recognized quality, to license and commercialize innovative and established products in segments such as oncology and hematology in Brazil and Latin America.
In APIs, focused on HIV, we are increasing our production and development capacity.
Blanver develops, produces and incorporates quality and competitive innovative products in its portfolio, always seeking to promote people’s health, quality of life and wellbeing.
We operate in the state of São Paulo, with corporate headquarters in the Morumbi neighborhood and two production plants – one in the city of Taboão da Serra, where our medicines are manufactured, and the other in Indaiatuba, for production of APIs.
To develop, manufacture and commercialize high quality and competitive innovative products for people’s health and wellbeing.
To be among the 500 largest Brazilian companies by 2023, with innovative medicines necessary for society.
- Respect for people
- Respect for standards
- Focused on quality
- Social responsibility